| Commodore Capital Lp |
Non-Executive |
Vistagen Therapeutics, Inc. (VTGN)
|
2023-08-07 |
$23.15 |
-85.9% |
775,756
|
$17,961,079 |
| Commodore Capital Lp |
Non-Executive |
Vera Therapeutics, Inc. (VERA)
|
2023-06-20 |
$15.17 |
151.6% |
448,217
|
$6,799,004 |
| Commodore Capital Lp |
Non-Executive |
Enliven Therapeutics, Inc. (ELVN)
|
2023-02-23 |
$22.07 |
-0.7% |
622
|
$13,723 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-11-24 |
$5.42 |
-79.7% |
2,922
|
$15,837 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-11-22 |
$5.48 |
-79.9% |
13,204
|
$72,329 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-11-11 |
$5.94 |
-81.5% |
17,563
|
$104,332 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-11-08 |
$5.99 |
-81.6% |
560
|
$3,354 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-11-05 |
$5.94 |
-81.5% |
9,200
|
$54,642 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-11-02 |
$5.64 |
-80.5% |
8,880
|
$50,083 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-10-29 |
$5.71 |
-80.7% |
44,651
|
$254,957 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-10-28 |
$5.48 |
-79.9% |
54,663
|
$299,422 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-10-22 |
$5.45 |
-79.8% |
60,445
|
$329,442 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-10-20 |
$5.19 |
-78.8% |
128,243
|
$665,237 |
| Commodore Capital Lp |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2021-10-18 |
$4.84 |
-77.3% |
162,194
|
$784,845 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-26.3% |
$-7,208,961 |
$27,408,286 |